SCHEMBL5887426

SCHEMBL5887426

COC1=CC[CH]C(c2ccccc2Cl)=C1c1ccc(C)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALKBH3 Q96Q83 1/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
CYP2C19 P33261 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP2A6 P11509 1/20 0.31
FFAR2 O15552 2/20 0.31
TUBB4A P04350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887625 0.91 HSP90AA1 (0.36) MEN1KMT2ANPC1ALDH1A1TP53
SCHEMBL5887347 0.86 MEN1 (0.35) MEN1KMT2APOLBTP53
SCHEMBL6047646 0.85 CYP2D6 (0.32) ALKBH3CYP2D6CYP2C9HPGDALOX15
SCHEMBL5887191 0.84 MEN1 (0.37) MEN1KMT2APOLBNPC1TP53
SCHEMBL5887667 0.82 NPC1 (0.39) MEN1KMT2ANPC1TP53TSHR
SCHEMBL5887143 0.81 PTGS2 (0.35) MEN1KMT2AALKBH3ALDH1A1RAB9A
SCHEMBL6047593 0.80 ALKBH3 (0.36) ALKBH3CYP2D6CYP2C9HPGDALOX15
SCHEMBL5887653 0.79 FFAR2 (0.40) KMT2ANPC1SMN1; SMN2FFAR2HSP90AA1
SCHEMBL5887105 0.78 ESR2 (0.35) POLBNPC1TP53TSHRSMN1; SMN2
SCHEMBL5887498 0.78 HSD11B1 (0.34) MEN1KMT2APOLBCYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed